Pannexin Channel Inhibition: An Evolving Target to Lower Blood Pressure? | Circ Res;122(4): 543-545, 2018 02 16. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL CLAP/WR-PAHO/WHO

Latin-American Center for Perinatology, Woman and Reproductive Health

Subject descriptor lookup Advanced Search

Pannexin Channel Inhibition: An Evolving Target to Lower Blood Pressure?

Huke, Sabine.

Affiliation

Huke S; From the Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham. hukes@uab.edu.

Circ Res ; 122(4): 543-545, 2018 02 16.

Article in En | MEDLINE | ID: mdl-29449359

Subject(s)

Antihypertensive Agents; Spironolactone; Aldosterone; Blood Pressure/drug effects; Mineralocorticoid Receptor Antagonists

Key words

Editorials; aldosterone; eplerenone; spironolactone

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spironolactone / Antihypertensive Agents Language: En Journal: Circ Res Year: 2018 Type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spironolactone / Antihypertensive Agents Language: En Journal: Circ Res Year: 2018 Type: Article